UCSF

Tagged: personalized medicines

Study discovers why leading gout medication is ineffective for many

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Genetic ancestry proven powerful in predicting lung function

Genetic ancestry can tell more about a person's potential lung function than the self-identified racial profile commonly used to determine normal lung function reference standards, according to the results of research led by UCSF and Northwestern University.

Burchard comments on asthma genetics

Asthma specialist and genetics researcher, Esteban G.

Pharmacogenomics research spans school agenda

Pharmacogenomics research at the UCSF School of Pharmacy extends from a better understanding of information derived from the Human Genome Project to research on specific genetic differences in humans and how they might affect an individual's response to a medication.

Phillips awarded $5 Million NCI grant to study personalized medicine

The wider world use of medical tests and treatments based on individual genetic differences is the focus of a new, US$5 million research program funded by the National Cancer Institute (NCI) and led by UCSF School of Pharmacy health economist Kathryn Phillips,

Burchard explores asthma risk in Latinos

What began as a fascination with fish when he was a child eventually led Esteban Burchard, MD to study genetic differences behind asthma risk.